360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Dupuytren's contracture

Type: Keyphrase

Name: Dupuytren's contracture

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Auxilium Pharmaceuticals Inc

Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference

CHESTERBROOK, Pa.(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on May 21, 2013. To access the live webcast, please log ... [Published Bio-Medicine - May 15 2013]

Entities: Auxilium Pharmaceuticals Inc, Global Health Ltd, UBS AG, Xiaflex

First reported May 10 2013 - Updated May 10 2013 - 4 reports

Phase II

BioSpecifics Technologies' Management Discusses Q1 2013 Results - Earnings Call Transcript

BioSpecifics Technologies Corp. (BSTC) Q1 2013 Earnings Call May 10, 2013 8:30 AM ETOperatorThank you for holding. Welcome to the BioSpecifics’ Q1 2013 Financial Results Conference Call. (Operator instructions.) I would like to introduce your host for ... [Published Seeking Alpha - May 10 2013]

Entities: Xiaflex, BioSpecifics Technologies Corp, Dupuytren's contracture, Phase II

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference

CHESTERBROOK, Pa.The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on May 15, 2013. To access the live webcast, please log on to Auxilium's website approximately fifteen minutes prior to ... [Published Bio-Medicine - May 10 2013]

Entities: Auxilium Pharmaceuticals Inc, Bank of America Merrill Lynch, Xiaflex, Health Care

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Margaret Thatcher

Memories of Margaret Thatcher: Dr Liam Fox

This is an extract from my new book MEMORIES OF MARGARET THATCHER , which is published today. A new extract will appear at 9am every day this week. The book contains 215 such essays by people from all walks of life who encountered the Iron Lady. You ... [Published Iain Dale's Diary - May 08 2013]

Entities: Margaret Thatcher, Liam Fox, Memory, Michael Ancram, Mallory Factor

First reported May 03 2013 - Updated May 03 2013 - 3 reports

BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013

LYNBROOK, N.Y.In order to participate in the conference call, please dial 1-800-860-2442 (domestic) or 1-412-858-4600 (international). The live webcast can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website ... [Published Bio-Medicine - May 03 2013]

Entities: BioSpecifics Technologies Corp, Dupuytren's contracture, collagenase

First reported May 03 2013 - Updated May 03 2013 - 1 reports

A mixed response to HIQA thresholds

Photo by West Coast Surfer / Mood Board / Rex FeaturesBy Lloyd Mudiwa.While the RCSI has come out in support of the principle of HIQA’s proposed clinical referral and treatment thresholds for high-volume elective surgical procedures, the IMO says it has ... [Published Irish Medical Times - May 03 2013]

Entities: Cataract, Ophthalmic, Ireland

First reported Apr 29 2013 - Updated Apr 30 2013 - 2 reports

Auxilium buys urology specialist

acquired Actient Holdings, a private urology specialty therapeutics company, for $585 millionActient‚s products include Testopel, a long-acting implantable testosterone replacement therapy; Edex, a non-oral drug for erectile dysfunction; and Osbon ErecAid, ... [Published Philadelphia Business Journal - Apr 29 2013]

Entities: Xiaflex, Erectile dysfunction, Testosterone

First reported Apr 16 2013 - Updated Apr 17 2013 - 2 reports

Stony Brook University to begin clinical trials for cellulite treatment

Specialists at Stony Brook University are planning to start placebo-controlled clinical trials to treat cellulite.The method is licensed to BioSpecifics Technologies and uses clostridial collagenase histolyticum (CCH), which is an injectable form of the ... [Published Labmate Online - Apr 17 2013]

Entities: Stony Brook University, Clinical trials, collagenase

First reported Mar 26 2013 - Updated Mar 26 2013 - 1 reports

Auxilium reports positive data from Xiaflex frozen shoulder syndrome phase IIa study

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced positive data for collagenase clostridium histolyticum or CCH which is being developed for the potential treatment, if approved by the US Food and Drug Administration (FDA), ... [Published PharmaBiz - Mar 26 2013]

Entities: Xiaflex, collagenase, Clostridium, Dupuytren's contracture, Collagen

First reported Mar 19 2013 - Updated Mar 19 2013 - 1 reports

Athlete with '3-pronged' hand leads way

When he was 39-years-old, Jerry Crimins was diagnosed with Dupuytren's contracture, an incurable hand deformity. Now, as he nears 80, he is routinely among the top-ranked tennis players of his age group in the region. In 1952, he scored 73 points in a ... [Published KOIN Local 6 - Mar 19 2013]

Entities: Dupuytren's contracture, Criminal, Oregon

Quotes

Lee encouraged people to involve their partners to help them deal with the disease. "If there is a significant other in your life, you guys need to come togethertogether with this. For me, that made all the difference."

Curved penis treatment promising [Published Health24 - May 16 2013]

"We are very pleased to have completed enrollment in our Phase II trials in canine and human lipoma and we remain on track to report top-line data for both trials in the second half of this year" reflected Thomas L Wegman, President of BioSpecifics. $ First Quarter 2013 Financial Results

BioSpecifics Technologies Corp. Reports First Quarter 2013 Financial Results PR Newswire [Published Yahoo! Finance - May 10 2013]

...we remain on track to report top-line data for both trials in the second half of this year," reflected Thomas L Wegman, President of BioSpecifics. "In addition, there are a number of exciting upcoming milestones for XIAFLEX this year. We are looking forward to the potential approval of XIAFLEX for the treatment of Peyronie's Disease in the third quarter of this year and if approved, we would anticipate the U S commercial launch in this indication in the fourth quarter of 2013. We are also eagerly awaiting the initiation of a new clinical trial for XIAFLEX in frozen shoulder syndrome in the second half of this year, following the announcement of the statistically significant top-line data from the Phase IIa study, as well as the initiation of a Phase II study in the cellulite indication during the same time period. Finally we believe there is tremendous potential for XIAFLEX in the treatment of many medical conditions caused by excess collagen accumulation and BioSpecifics will continue to devote its efforts to the development in new clinical indications in the future."

BioSpecifics Technologies Corp. Reports First Quarter 2013 Financial Results [Published Staten Island Live - May 10 2013]

Hellstrom W, et al "Composite responders showed improvement in both penile curvature deformity and symptom bother in two large double-blind, randomized, placebo-controlled phase III studies of collagenase clostridium histolyticum in the treatment of Peyronie's disease" AUA 2013; Abstract 1658

High Response to Enzyme in Peyronie's [Published MedPage Today - May 08 2013]

More Content

sort by: Date \| Relevance
Auxilium CEO Goes Against Type, Buying Instead ... [Published TheStreet.com - May 22 2013]
Curved penis treatment promising [Published Health24 - May 16 2013]
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published Bio-Medicine - May 15 2013]
BioSpecifics Technologies' Management Discusses... [Published Seeking Alpha - May 10 2013]
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published Bio-Medicine - May 10 2013]
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published PR Newswire - May 10 2013]
BioSpecifics Technologies Corp. Reports First Q... [Published Yahoo! Finance - May 10 2013]
BioSpecifics Technologies Corp. Reports First Q... [Published ADVFN UK - May 10 2013]
BioSpecifics Technologies Corp. Reports First Q... [Published Staten Island Live - May 10 2013]
High Response to Enzyme in Peyronie's [Published MedPage Today - May 08 2013]
Treatment for Painful Curved Penis Shows Promise [Published Health Finder - May 08 2013]
Memories of Margaret Thatcher: Dr Liam Fox [Published Iain Dale's Diary - May 08 2013]
Deals of the Week Looks at Ultra-Orphan Drug Pr... [Published The IN VIVO Blog - May 05 2013]
BioSpecifics Technologies Corp. to Host Confere... [Published Bio-Medicine - May 03 2013]
A mixed response to HIQA thresholds [Published Irish Medical Times - May 03 2013]
BioSpecifics Technologies Corp. to Host Confere... [Published FinanzNachrichten.de - May 03 2013]
BioSpecifics Technologies Corp. to Host Confere... [Published WTNZ - May 03 2013]
Weak Quarter At Auxilium Overshadows Execution ... [Published Seeking Alpha - May 01 2013]
Auxilium slumps on 1Q sales, makes $585M purchase [Published CNBC - Apr 29 2013]
Auxilium buys urology specialist [Published Philadelphia Business Journal - Apr 29 2013]
Auxilium Pharmaceuticals Acquires Actient Holdi... [Published Citybizlist - Apr 29 2013]
Auxilium CEO Goes Against Type, Buying Instead ... [Published TheStreet.com - Apr 29 2013]
Auxilium Pharmaceuticals, Inc, Announces First ... [Published WXVT-TV - Apr 29 2013]
Auxilium Pharmaceuticals, Inc. (AUXL) - Financi... [Published TransWorldNews - Apr 21 2013]
Stony Brook University to begin clinical trials... [Published Labmate Online - Apr 17 2013]
Clinical Trials for Cellulite Treatment on the ... [Published Newswise - Apr 16 2013]
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire - Mar 26 2013]
Auxilium reports positive data from Xiaflex fro... [Published PharmaBiz - Mar 26 2013]
Athlete with '3-pronged' hand leads way [Published KOIN Local 6 - Mar 19 2013]
US FDA accepts Auxilium Pharma's Xiaflex sBLA f... [Published PharmaBiz - Dec 29 2012]

Blogs

sort by: Date \| Relevance
Memories of Margaret Thatcher: Dr Liam Fox [Published Iain Dale's Diary - May 08 2013] This is an extract from my new book MEMORIES OF MARGARET THATCHER , which is published today. A new extract will appear at 9am every day this week. The book contains 215 such essays by people from all walks of life who encountered the Iron Lady. You ...
Deals of the Week Looks at Ultra-Orphan Drug Pr... [Published The IN VIVO Blog - May 05 2013] In the first half of 2013, two drugs will have launched in the US priced at $250,000 per patient annually: Both address serious, ultra-rare diseases and are backed by KOLs and patients. But the similarities stop there. Three months into its launch, ...

Press Releases

sort by: Date \| Relevance
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published PR Newswire - May 10 2013]
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire - Mar 26 2013]